The collaboration will initially focus on addressing interventions recommended for Medicare Advantage members of joint clients, but it may expand into additional services.
Altuviiio is an injectable medicine used to control and reduce the number of bleeding episodes in people with hemophilia A (congenital Factor VIII deficiency).
